Hemochromatosis mutations C282Y and H63D in 'cis' phase

Clinical Genetics

Volumn 60, Issue 1, 2001, Pages 68-72

  Best, L G ^a,d   Harris, P E ^b   Spriggs, E L ^c  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d NONE   (United States)

Author keywords

Diagnosis; Genetic screening; Genetics population; Hemochromatosis; Linkage disequilibrium; Mutation

Indexed keywords

FERRITIN; GENE PRODUCT;

AGED; ARTICLE; BELGIUM; CASE REPORT; FAMILY HISTORY; FEMALE; FERRITIN BLOOD LEVEL; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC RISK; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INHERITANCE; IRELAND; PARENTHOOD; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGENY; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS;

AGED; AMINO ACID SUBSTITUTION; DNA; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; GENOTYPE; HEMOCHROMATOSIS; HUMANS; MALE; MUTATION; PEDIGREE;

EID: 0034919706     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2001.600111.x     Document Type: Article

References (29)

1. Iron metabolism and related disorders
2. Molecular medicine and hemochromatosis: At the crossroads
3. Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing
4. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
5. Prevalence of the C282Y mutation in Brittany: Penetrance of genetic hemochromatosis?
6. Global prevalence of putative haemochromatosis mutations
7. UK Haemochromatosis Consortium. A simple genetic test identifies 90% of UK patients with haemochromatosis
8. Haemochromatosis and HLA-H
9. Phenotypic expression of HFE mutations: A French study of 1110 unrelated iron-overloaded patients and relatives
10. UK Haemochromatosis Consortium
11. Detection of an unusual combination of mutations in the HFE gene for hemochromatosis
12. An HFE intronic variant promotes misdiagnosis of hereditary hemochromatosis
13. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis
14. H63D is an haemochromatosis associated allele
15. A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria
16. Diagnosis of hemochromatosis in family members of probands: A comparison of phenotyping and HFE genotyping
17. Hemochromatosis in Ireland and HFE
18. Linkage disequilibrium analysis in Australian haemochromatosis patients indicates bipartite association with clinical expression
19. Genotypic/phenotypic correlations in genetic hemochromatosis: Evolution of diagnostic criteria
20. C282Y and H63D mutations of the hemochromatosis candidate gene in type 2 diabetes
21. Patients with type 2 diabetes have a high frequency of the C282Y mutation of the hemochromatosis gene
22. A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations
23. High incidence of the Cys282Tyr mutation in the HFE gene in the Irish population - Implications for haemochromatosis
24. A population-based study of the clinical expression of the hemochromatosis gene
25. Prevalence of the Cys282Tyr and His63Asp gene mutations in Spanish patients with hereditary hemochromatosis and in controls
26. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis
27. Diagnosis of hemochromatosis in family members of probands: A comparison of phenotyping and HFE genotyping
28. Haemochromatosis and HLA-H
29. Haemochromatosis, HFE and genetic complexity